Connectez-vous pour enregistrer et recevoir des mises à jour.
When AI designs a drug, who gets the credit?
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
Articles sources
MIT Technology Review (United States) | Aug 21, 2026
Your votes count
No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.
Traduction en attente
Traduction en attente
Traduction en attente
Traduction en attente
Traduction en attente
Traduction en attente
Traduction en attente
Traduction en attente
Traduction en attente
Traduction en attente
💡 How This Works
- • Add Statements: Post claims or questions (10-500 characters)
- • Vote: Agree, Disagree, or Unsure on each statement
- • Respond: Add detailed pro/con responses with evidence
- • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement
Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.
Support us